Search results
Could past COVID infections protect against certain colds?
WGRZ-TV Buffalo· 20 hours agoIf you’ve been sick with COVID-19, you may have some protection against certain versions of the...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 4 hours agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and olderHigher efficacy was observed in mRNA-1283 compared
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine
US News & World Report· 3 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is showing positive results among older adults in trials, maker Moderna announced Monday. The shot ...
Column: After smearing Anthony Fauci, House Republicans proceed to defame a prominent vaccine...
LA Times via Yahoo News· 7 days agoAs I've reported, learned scientific opinion overwhelmingly supports the theory that the pandemic...
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Forbes· 1 day agoAround 25 million Americans are affected by the eye disease Demodex blepharitis, which is caused by...
‘My whole skull was throbbing’: How it feels to survive bird flu
The Telegraph via Yahoo News· 3 days agoIt sounds like something out of a science fiction film but clade2.3.4.4b, as the latest major strain...
How Common Is Long COVID?
Journal of the American Medical Association· 6 days agoThis Medical News article discusses new US household survey data that found differences in long COVID rates based on preexisting chronic conditions and other factors.
Chronotherapy: Why Timing Drugs to Our Body Clocks May Work
Medscape· 3 days agoA new analysis published in this month's issue of The Lancet journal's eClinicalMedicine suggests:...
Combo COVID/flu vaccine elicits higher immune response in trial
UPI· 3 days agoThe new vaccine contains components of mRNA-1010, Moderna's vaccine candidate for seasonal...
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral...
The News & Observer· 2 days agoA First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More